NT5E and glioblastoma: Also related to GBM, the possible use of a nasal administration-mixed cationic nanoemulsion based on CD73-siRNA is being investigated [75]; CD73 is an extracellular nucleotidase that exerts immunosuppressive effects and induces drug resistance in GBM [76].